A novel SOD1-ALS mutation separates central and peripheral effects of mutant SOD1 toxicity

Area of Science:

• Neuroscience
• Genetics
• Molecular Biology

Background:

• Transgenic mouse models expressing mutant superoxide dismutase 1 (SOD1) are crucial for studying amyotrophic lateral sclerosis (ALS).
• Existing models often overexpress mutant SOD1, potentially leading to non-pathological phenotypes.
• A need exists for models reflecting endogenous expression levels of specific familial ALS (fALS) mutations.

Purpose of the Study:

• To analyze a novel mouse model with an endogenous Sod1 point mutation (D83G) mirroring a human fALS mutation.
• To investigate the consequences of this mutation on motor neuron degeneration and associated pathologies at physiological expression levels.

Main Methods:

• Generation and analysis of homozygous Sod1(D83G/D83G) mice with a point mutation in the endogenous Sod1 gene.
• Assessment of motor neuron degeneration (lower and upper) and disease progression.
• Evaluation of SOD1 protein activity, stability, and associated peripheral phenotypes.

Main Results:

• Sod1(D83G/D83G) mice exhibit progressive degeneration of lower and upper motor neurons.
• Motor neuron degeneration halts in early adulthood, and mice do not develop paralysis.
• The D83G mutation impairs SOD1 dismutase activity and protein stability, leading to distal axonopathy and hepatocellular carcinoma, similar to Sod1 null mice.

Conclusions:

• This model recapitulates key aspects of fALS motor neuron degeneration at endogenous expression levels.
• The findings help separate central motor neuron pathology from peripheral effects caused by the fALS mutation.
• These mice provide a unique tool for dissecting the complex pathophysiology of ALS and SOD1-related disorders.